SUN NELSON (Chief Financial Officer) purchased 2.8% of their position (3K shares) of AARDVARK THERAPEUTICS, INC. on the open market
Open‑market purchase worth $43.2K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/12/2025ACC: 0001193125-25-318070
Officer· Chief Financial Officer
Since Feb 2026
+3K
Net shares
Net buyer
$43.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
3K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3K
Price / share
$14.40
Trade value
$43.20K
% of position
2.8%
12/11/2025
105.48K→108.48K
Total
Net shares
+3K
Net value
$43.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/11/2025 | P · Purchase | +3K | $14.40 | $43.20K | 2.8% | 105.48K | 108.48K |
| Total | +3K | $43.20K | ||||||
Derivative Transactions0
No derivative transactions reported